Global nanotechnology company pSivida Ltd is pleased to announce that in connection with the NASDAQ listing, pSivida will be hosting an investor meeting on Thursday 27th January.
pSivida's Managing Director Mr. Gavin Rezos will discuss pSivida’s use of BioSilicon™ to develop innovative methods of controllable drug delivery and diagnostics, the company’s clinical trial timeline, product pipeline and partnerships, and commercial outlook for the future.
Those who wish to access the webcast may log onto http://www.psivida.com/News/Presentations.asp.
The webcast will be available beginning at 1:00 p.m. US Eastern Time.
PSD Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.